Pulmatrix (PULM) investor relations material

Opening remarks and agenda

• Special meeting held in lieu of the annual meeting; Peter Ludlum served as chair and secretary, then turned meeting conduct over to consultant Jordan Medalia.

• Record date was August 28, 2026; polls opened for eight matters, with formal business followed by an operations update and voting results.

Specific resolutions to be voted on

• Approve issuance of common shares representing more than 20% of pre-merger shares to Eos SENOLYTIX stockholders and the merger-related change of control under Nasdaq rules 5635(a) and (b).

• Approve a reverse split at a board- and Eos-agreed ratio of 1-for-2 to 1-for-10, or any ratio in between; increase authorized common shares from 200 million to 250 million.

• Ratify CBIZ CPAs P.C. for FY ended December 31, 2026; if the merger closes, Stephano Slack LLC is expected to serve as independent auditor.

• Elect Michael J. Higgins and Anand Varadan as Class III directors through the 2029 annual meeting; approve advisory executive compensation and vote frequency, plus the Eos Incentive Plan.

Board and executive committee updates

• Peter Ludlum was identified as Interim CEO and Interim CFO; directors introduced were Michael J. Higgins, Richard Batycky, Christopher Cabell, Anand Varadan and Todd Bazemore.

• Higgins and Varadan were nominated for Class III terms through the 2029 annual meeting; if the merger closes, the board will be reconstituted under the merger agreement.